Clinical characteristics for individual samples identified by the PCRS and placed in Groups 3 and 4.

Table 3: Clinical characteristics for individual samples identified by the PCRS and placed in Groups 3 and 4.

Group	Age	tPSA (ng/ml)	Clinical characteristics
Group 3	72	4.06	Normal
Group 3	61	4.48	BPE Repeat testing after 2 years
Group 3	63	4.31	BPE Repeat testing after 2 years
Group 3	63	4.33	Prostate examined, no signs of cancer
Group 4	55	4.27	Prostate cancer
Group 4	64	236	Prostate cancer Stage 4
Group 4	59	4.22	Nocturia Advised to arrange prostate examination with NHS GP
Group 4	58	4.74	Under the care of a consultant urologist Diagnosed with BPE Continued monitoring (watch and wait) Repeat test after 6 months
Group 4	58	5.77
Group 4	72	5.35	Under the care of a consultant urologist Diagnosed with BPE Continued monitoring (watch and wait)
Group 4	43	4.56	Pelvic and pubic pain, urinary dribbling Advised to arrange assessment with consultant urologist
Group 4	61	4.23	Under the care of a consultant urologist Consultant urologist satisfied that no further action
Group 4	73	7.29	History of recurrent UTI's and urological problems
Group 4	63	4.64	Under the care of a consultant urologist Continued monitoring (watch and wait)